Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)

CNY 13.44

(-0.07%)

Revenue Summary of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's latest annual revenue in 2023 was 3.93 Billion CNY , up 4.39% from previous year.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's latest quarterly revenue in 2024 Q3 was 945.35 Million CNY , down -16.56% from previous quarter.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported a annual revenue of 3.71 Billion CNY in annual revenue 2022, up 0.71% from previous year.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported a annual revenue of 3.68 Billion CNY in annual revenue 2021, up 26.48% from previous year.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported a quarterly revenue of 945.35 Million CNY for 2024 Q3, down -16.56% from previous quarter.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported a quarterly revenue of 1 Billion CNY for 2024 Q1, up 30.49% from previous quarter.

Annual Revenue Chart of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (2023 - 2013)

Historical Annual Revenue of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (2023 - 2013)

Year Revenue Revenue Growth
2023 3.93 Billion CNY 4.39%
2022 3.71 Billion CNY 0.71%
2021 3.68 Billion CNY 26.48%
2020 2.91 Billion CNY 18.03%
2019 2.46 Billion CNY 45.25%
2018 1.7 Billion CNY 52.81%
2017 1.11 Billion CNY 91.22%
2016 581.91 Million CNY 24.15%
2015 468.72 Million CNY 12.64%
2014 416.12 Million CNY -16.75%
2013 499.81 Million CNY 0.0%

Peer Revenue Comparison of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

Name Revenue Revenue Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 59.279%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY -35.11%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 94.794%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 74.369%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 53.994%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 49.56%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 52.186%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY -1897.338%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 83.843%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY -595.324%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 76.383%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY -509.546%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 27.282%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY -356.643%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 52.126%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY -109.969%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY -223.172%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 28.823%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 74.527%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 62.162%
Nanjing Well Pharmaceutical Group Co.,Ltd. 1.15 Billion CNY -240.133%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY -5.278%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY -18.72%
Shenzhen Chipscreen Biosciences Co., Ltd. 515.78 Million CNY -662.214%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY -41.524%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 19.237%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY -577.758%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 77.989%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 48.464%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY -365.064%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 61.153%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 61.54%
Tibet Weixinkang Medicine Co., Ltd. 1.32 Billion CNY -197.236%
China National Medicines Corporation Ltd. 49.69 Billion CNY 92.089%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 62.1%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY -25.276%
ChengDu ShengNuo Biotec Co.,Ltd. 430.98 Million CNY -812.182%
Dali Pharmaceuticalco.,Ltd 87.26 Million CNY -4404.857%
Changchun BCHT Biotechnology Co. 1.81 Billion CNY -117.006%
Zhejiang Shengda Bio-Pharm Co., Ltd. 727.4 Million CNY -440.467%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY -1246.737%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 9.152%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY -25.333%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 11.899%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY -174.387%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 90.504%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 6.04%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY -141.405%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY -26.961%
Guobang Pharma Ltd. 5.34 Billion CNY 26.509%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 672.96 Million CNY -484.193%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 19.34%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 70.318%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY -80.543%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY -89.93%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY -3.499%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 932.12 Million CNY -321.768%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 67.051%
Shanghai Yizhong Pharmaceutical Co., Ltd. 360.25 Million CNY -991.282%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY -26.976%
Sichuan Huiyu Pharmaceutical Co., Ltd. 920.34 Million CNY -327.163%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY -485.353%
CanSino Biologics Inc. 345.18 Million CNY -1038.932%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY -80.828%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 36.041%